This chip stock will ride the AI wave to a 30% gain over the next 12 months, CLSA says

CLSA initiated coverage on Micron Technology (MU) with an Outperform rating and a $155 per share price target, implying approximately 33% upside. The investment firm is bullish on Micron's prospects, citing its strong position to capitalize on the AI boom through robust demand for High Bandwidth Memory (HBM) and an anticipated healthy demand-supply balance in conventional DRAM from 2H25-2026. This positive outlook underscores Micron's technological prowess and execution in ramping up HBM3E, positioning it as a key beneficiary of rising global AI infrastructure spending.

Analysis

CLSA has initiated coverage on Micron Technology (MU) with an Outperform rating and a $155 price target, suggesting a potential 33% upside from its $116.50 closing price. The core of this bullish thesis rests on Micron's strategic position to capitalize on the artificial intelligence boom. The analysis highlights two primary drivers: first, surging demand for High Bandwidth Memory (HBM) from AI customers, where Micron is demonstrating strong execution with a faster-than-expected ramp-up of its HBM3E product for four major clients. Second, the report anticipates a favorable supply-demand balance for conventional DRAM in the second half of 2025 and into 2026, as the industry's focus on HBM production naturally constrains the supply of traditional memory. This outlook is presented even as Micron's shares have already posted a significant gain of nearly 40% year-to-date, indicating that CLSA sees further runway despite the stock's recent strong performance.

Key Decisions for Investors

• Investors could view this 'Outperform' initiation as a strong signal to increase exposure to Micron, as the thesis links the company directly to the secular growth trend of AI infrastructure spending.
• Given the stock's substantial 40% year-to-date appreciation, it is critical to monitor the company's execution on its HBM3E ramp-up, as any failure to meet these now-heightened expectations could introduce significant downside risk.
• The projected tightening of the conventional DRAM market in 2H25-2026 presents a secondary catalyst, and investors should watch for industry-wide data points that confirm this supply constraint thesis.